Transformation of the nitrogen cycle: recent trends, questions, and potential solutions

Humans continue to transform the global nitrogen cycle at a record pace, reflecting an increased combustion of fossil fuels, growing demand for nitrogen in agriculture and industry, and pervasive inefficiencies in its use. Much anthropogenic nitrogen is lost to air, water, and land to cause a cascade of environmental and human health problems. Simultaneously, food production in some parts of the world is nitrogen-deficient, highlighting inequities in the distribution of nitrogen-containing fertilizers. Optimizing the need for a key human resource while minimizing its negative consequences requires an integrated interdisciplinary approach and the development of strategies to decrease nitrogen-containing waste.     

Correlation between plasma alpha-melanocyte-stimulating hormone concentration and body mass index in healthy horses

OBJECTIVE: To evaluate the correlation between plasma alpha-melanocyte-stimulating hormone (alpha-MSH) concentration and body mass index (BMI) in healthy horses. ANIMALS: 82 healthy horses. PROCEDURE: Plasma alpha-MSH concentration was determined by radioimmunoassay. At the time blood samples were collected, body condition scores (BCS) were determined and measurements of girth circumference, body length, and height were obtained. Weight was estimated by use of the following formula: estimated weight (kg) = [girth (cm)2 x length (cm)]/11,877. Body mass index was calculated as estimated weight (kg)/height (m)2. RESULTS: A correlation was found between BMI and BCS (rs = 0.60 [95% confidence interval (CI), 0.44 to 0.731). A weak correlation was found between plasma alpha-MSH concentration and BMI (rs = 0.25 [95% CI, 0.03 to 0.45]) and BCS (rs = 0.26 [95% CI, 0.04 to 0.46]). A correlation was found between plasma alpha-MSH concentration and BMI in horses > or = 10 years old (rs = 0.49 [95% CI, 0.20 to 0.69]) but not in horses < 10 years old (rs = -0.04). Horses in the upper quartile of BMI had significantly greater plasma alpha-MSH concentration (median, 9.1 pmol/L; range, 2.0 to 95.3 pmol/L) than horses in the lowest quartile of BMI (median, 70 pmol/L; range, 3.6 to 15.7 pmol/L). CONCLUSIONS AND CLINICAL RELEVANCE: A correlation exists between plasma alpha-MSH concentration and BMI in horses. Further study is required to determine whether melanocortin receptor defects underlie this correlation or, alternately, whether plasma alpha-MSH concentration is simply a correlate of adiposity.     

Spirocerca lupi infection in the dog: a review

Spirocercosis is a disease occurring predominantly in Canidae, caused by the nematode Spirocerca lupi. Typical clinical signs are regurgitation, vomiting and dyspnoea. The life-cycle involves an intermediate (coprophagous beetle) and a variety of paratenic hosts. Larvae follow a specific migratory route, penetrating the gastric mucosa of the host, migrating along arteries, maturing in the thoracic aorta before eventually moving to the caudal oesophagus. Here the worm lives in nodules and passes larvated eggs which can be detected using zinc sulphate faecal flotation. Histologically, the mature oesophageal nodule is composed mostly of actively dividing fibroblasts. Spirocerca lupi-associated oesophageal sarcomas may occur and damage to the aorta results in aneurysms. A pathognomonic lesion for spirocercosis is spondylitis of the thoracic vertebrae. Primary radiological lesions include an oesophageal mass, usually in the terminal oesophagus, spondylitis, and undulation of the aortic border. Contrast radiography and computed tomography are helpful additional emerging modalities. Oesophageal endoscopy has a greater diagnostic sensitivity than radiography. Endoscopic biopsies are not sensitive for detecting neoplastic transformation. Doramectin is the current drug of choice, effectively killing adult worms and decreasing egg shedding. Early diagnosis of infection is still a challenge and to date no ideal regimen for prophylaxis has been published.     

Milrinone

Milrinone, a positive inotropic drug with vasodilating properties, was administered at doses of 0.5 to 1 mg/kg orally twice daily to 29 dogs with moderate to severe congestive heart failure (CHF). Significant echocardiographic improvement in ventricular systolic function was observed after 3 days of administration of milrinone and at the patients' last echocardiographic observation (day 21 in 25 subjects, day 7 in 2 subjects, and day 3 in 2 subjects). Echocardiographic shortening fraction at the initial measurement had a median increase of 6.14% (P less than 0.001), and for the last observation a 2.83% increase (P less than 0.005). Most patients also showed improvement in their clinical signs as assessed by the veterinarian (72%) and by owner's evaluation (81%). No consistent problem or adverse reaction to milrinone was observed, except for a small number of clinically manageable ventricular dysrhythmias. Milrinone appears in this trial to be effective for the treatment of advanced CHF in dogs.     

What the soil reveals: Potential total ecosystem C stores of the Pacific Northwest region, USA

How much organic C can a region naturally store in its ecosystems? How can this be determined, when land management has altered the vegetation of the landscape substantially? The answers may lie in the soil: this study synthesized the spatial distribution of soil properties derived from the state soils geographic database with empirical measurements of old-growth forest ecosystem C to yield a regional distribution of potential maximum total-ecosystem organic C stores. The region under consideration is 179,000 square kilometers extending from the southern Oregon border to the northern Washington border, and from the Pacific Ocean to the east side of the Cascade Mountains. Total ecosystem organic C (TEC) was measured in 16 diverse old-growth forests encompassing 35 stands and 79 pedons to a depth of 100 cm. The TEC ranged between 185 and 1200 Mg C ha⁻¹. On an average, 63% of TEC was in the vegetation, 13% in woody detritus, 3% in the forest floor, 7% in the 0–20 cm mineral soil, and 13% in 20–100 cm mineral soil. The TEC was strongly related to soil organic C (SOC) in the 0–20 cm mineral soil, yielding a monotonically increasing, curvilinear relation. To apply this relation to estimate the TEC distribution throughout the region, 211 map units of the state soils geographic database (STATSGO) were used. The SOC in the 0–20 cm mineral soil of the map units was consistent with values from previously measured pedons distributed throughout the region. Resampling of 13 second-growth forests 25 years after initial sampling indicated no regional change in mineral SOC, and supported the use of a static state soils map. The SOC spatial distribution combined with the quantitative old-growth TEC–SOC relation yielded an estimate of potential TEC storage throughout the region under the hypothetical condition of old-growth forest coverage. The area-weighted TEC was 760 Mg C ha⁻¹. This is 100 Mg C ha⁻¹ more than a previous estimate based on a coarser resolution of six physiographic provinces, and 400 Mg C ha⁻¹ more than current regional stores. The map of potential TEC may be useful in forecasting regional C dynamics and in land-management decisions related to C sequestration.     

Severe hematometra in a dog with cystic endometrial hyperplasia/pyometra complex.

An 18-month-old, intact female German shepherd dog was presented for evaluation of severe, frank hemorrhage from the vulva. A complete blood count, serum biochemical analysis, and urinalysis supported acute hemorrhage. Abdominal radiographs were unremarkable. Abdominal ultrasound demonstrated that the uterine body and cranial vaginal lumen were fluid-filled and contained hyperechoic, polypoid masses that were suspected to be blood clots. Exploratory laparotomy revealed a mildly enlarged uterus with a diffuse, cystic endometrium; significant amounts of blood and blood clots within the lumen; and several focal accumulations of yellow fluid presumed to be a purulent exudate. Histopathology confirmed severe, cystic, endometrial hyperplasia and pyometra complex.